BCBS North Carolina Medical Policy Updates – December 2018

Click here to view the Blue Cross Blue Shield North Carolina Medical Policy Updates »

December 2018 Medical Policy Updates:

• Allergy Immunotherapy (Desensitization)
• Alpha 1-Antitrypsin Inhibitor Therapy
• Biofeedback
• Biofeedback as a Treatment of Pain
• Bioimpedance Devices for Detection of Lymphedema
• Blinatumomab (Blincyto)
• Capsule Endoscopy, Wireless
• Chromoendoscopy as an Adjunct to Colonoscopy
• Confocal Laser Endomicroscopy
• Daunorubicin and Cytarabine (Vyxeos)
• Electrostimulation and Electromagnetic Therapy for Wounds
• External Defibrillators
• Extracorporeal Shock Wave Treatment for Musculoskeletal Conditions and Wound Healing
• Fecal Calprotectin Test
• Fecal Microbiota Transplantation
• Focal Treatments for Prostate Cancer
• Gastroesophageal Reflux Disease, Transendoscopic Therapies
• Genetic Testing For Colon Cancer
• Genetic Testing for FLT3, NPM1 and CEBPA Mutations in Acute Myeloid Leukemia
• Genetic Testing for Myeloproliferative Neoplasms
• Growth Factors in Wound Healing
• Handheld Radiofrequency Spectroscopy for Intraoperative Assessment of Surgical Margins during Breast-Conserving Surgery
• Hematopoietic Cell Transplantation for Plasma Cell Dyscrasias, Including Multiple Myeloma and POEMS Syndrome
• Hematopoietic Stem-Cell Transplantation for Primary Amyloidosis
• Hematopoietic Stem-Cell Transplantation for Solid Tumors Childhood
• Hematopoietic Stem-Cell Transplantation for Waldenstrom Macroglobulinemia
• Hematopoietic Stem-Cell Transplantation in the Treatment of Germ Cell Tumors
• Ingestible pH and Pressure Capsule
• Injectable Bulking Agents for the Treatment of Urinary and Fecal Incontinence
• Injectable Clostridial Collagenase for Fibroproliferative Disorders
• Inotuzumab (Besponsa)
• Intensity Modulated Radiation Therapy for Tumors of the Central Nervous System
• Interleukin 5 Antagonists
• Lutathera® (lutetium Lu 177 dotatate)
• Magnetic Esophageal Sphincter Augmentation to Treat Gastroesophageal Reflux Disease (GERD)
• New-To-Market Specialty Drug PPA Requirements
• Non-Contact Ultrasound Treatment for Wounds
• Noninvasive Respiratory Assist Devices
• Nusinersin Spinraza
• Olaratumab (Lartruvo)
• Pelvic Floor Stimulation as a Treatment of Urinary and Fecal Incontinence
• Percutaneous Intradiscal Electrothermal Annuloplasty, Radiofrequency Annuloplasty, and Biacuplasty
• Percutaneous Tibial Nerve Stimulation for Voiding Dysfunction
• Plugs for Fistula Repair
• Radiofrequency Ablation of Miscellaneous Solid Tumors Excluding Liver Tumors
• Sacral Nerve Neuromodulation/Stimulation for Pelvic Floor Dysfunction
• Saturation Biopsy for Diagnosis, Staging, and Management of Prostate Cancer
• Subtalar Arthroereisis
• Testosterone Pellet Implantation for Androgen Deficiency
• Transanal Endoscopic Microsurgery
• Transanal Radiofrequency Treatment
• Treatment of Hereditary Angioedema
• Tumor Treatment Fields Therapy For Glioblastoma
• Tumor-Treatment Fields Therapy
• Urinary Tumor Markers for Bladder Cancer
• Ustekinumab Stelara
• Vesicoureteral Reflux, Treatment with Periureteral Bulking Agents
• Xolair Omalizumab

Click here to view the Blue Cross Blue Shield North Carolina Medical Policy Updates »

Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.

Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!

Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.

Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.